Guorui Ruan
Overview
Explore the profile of Guorui Ruan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao M, Liao M, Gale R, Zhang M, Wu L, Yan N, et al.
Biomedicines
. 2025 Jan;
12(12.
PMID: 39767827
: About half of adults with acute myeloid leukemia with normal cytogenetics (CN-AML) have mutations. There is controversy regarding their prognosis and best therapy. : We studied 150 subjects with...
2.
Duan W, Jia J, Wang J, Liu X, Yu W, Zhu X, et al.
Ann Hematol
. 2024 Sep;
103(11):4525-4535.
PMID: 39287653
Co-occurring mutations are frequently observed in acute myeloid leukemia (AML) with NPM1 mutation, and NPM1 measurable residual disease (MRD) is an effective prognostic biomarker. This retrospective study investigated the impact...
3.
Pan X, Chang Y, Ruan G, Zhou S, Jiang H, Jiang Q, et al.
Clin Exp Med
. 2024 Feb;
24(1):35.
PMID: 38349460
Despite the high incidence of tet methylcytosine dioxygenase 2 (TET2) mutations in acute myeloid leukemia (AML), the prognostic implications of these mutations in three AML risk groups based on the...
4.
Pan X, Chang Y, Ruan G, Wei F, Jiang H, Jiang Q, et al.
Br J Haematol
. 2023 Aug;
203(2):212-223.
PMID: 37621257
The prognosis of acute myeloid leukaemia (AML) patients carrying NPM1 mutations is significantly worse when accompanied by FLT3-ITD mutations. However, accurate quantitative detection of FLT3-ITD mutations remains challenging. To identify...
5.
Tang F, Zhao X, Ruan G, Jiang Q, Jiang H, Xu L, et al.
Hematol Oncol
. 2023 Jun;
41(4):733-742.
PMID: 37272204
According to the 2022 European LeukemiaNet, all acute myeloid leukemia (AML) cases with FLT3-ITD mutations are now categorized as intermediate risk irrespective of the FLT3-ITD allelic ratio or concurrent presence...
6.
Ma L, Wen X, Xue H, Zhao L, Ding Y, Xu F, et al.
Obesity (Silver Spring)
. 2022 Jan;
30(2):320-337.
PMID: 35088555
Objective: This review examines main government and nongovernmental institutions for childhood obesity prevention and control in China, as well as major national interventions for childhood obesity. Methods: PubMed, China National...
7.
Huang Z, Jia Y, Ruan G, Zuo Y, Wu J, Lu A, et al.
Pediatr Hematol Oncol
. 2021 Sep;
39(3):243-253.
PMID: 34582325
To assess the prognostic effect of different levels of IKZF1 gene deletions in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL). IKZF1 Δ2-8/ALB deletions were quantified using multiplex real-time quantitative PCR...
8.
Yan A, Sun X, Zheng J, Mi B, Zuo H, Ruan G, et al.
Diabetes Res Clin Pract
. 2021 Jun;
177:108881.
PMID: 34120759
No abstract available.
9.
Yang F, Li Q, Xiang J, Zhang H, Sun H, Ruan G, et al.
Mol Omics
. 2020 Dec;
17(1):153-159.
PMID: 33295915
Acute lymphoblastic leukemia (ALL) is one of the common malignant tumors. Compared with childhood ALL, the treatment effect of adult B-cell ALL is less effective and remains a big challenge....
10.
Yan A, Sun X, Zheng J, Mi B, Zuo H, Ruan G, et al.
Diabetes Res Clin Pract
. 2020 Jul;
167:108350.
PMID: 32710996
Aims: To examine perceived infection risk of COVID-19 and the health and related behavior changes among people with diabetes, compared with people without diabetes, and to examine factors associated with...